P&T COMMUNITY
 
MediMedia Managed Markets
Our
Other
Journal
Managed Care magazine
Login / Register
Join Us  Facebook  Twitter  Linked In
About P&T Journal
Contacts:
Editorial: Sonja Sherritze, Editor
Advertising: Maureen Dwyer Liberti,
    Vice President, Group Publisher

Production: Mary Ellen Curry,
    Director of Production Services

Circulation: Jackie Ott, Circulation Manager


Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints


Recent Issues

March 2013

Features

Letter to the Editor

Transforming the P&T Committee

Fred J. Pane, RPh, BSPharm, FASHP

Editorial

Do Antidepressant Medications Work?

Treatment-resistant depression is extremely common—but does that mean there is no place for antidepressants?
David A. Casey, MD

Health Care & Law

The Affordable Care Act

New Features in 2013

Among the health care changes this year: revenues to hospitals will be lower, payments to physicians will be modified, and more patients will be covered by Medicaid.
E. Paul Larrat, RPh, PhD; Rita M. Marcoux, RPh, MBA; and F. Randy Vogenberg, RPh, PhD

Differing Views on ‘Essential Health Benefits’ Extend to Drug Coverage

Composition of Formularies Is a Point of Contention

it is unclear how the final rule on “clinically appropriate” and “medically necessary” drugs will apply to hospital formularies and Part B drugs given in the doctor’s office.
Stephen Barlas

Pharmacovigilance Forum

ACE Inhibitor–Related Angioedema

Are Your Patients at Risk?

The author presents 4 case histories of patients who experienced angioedema after treatment with various ACE inhibitors in what some have called a “silent epidemic.”
Michele B. Kaufman, PharmD, RPh

Improving Anticoagulation Management In Patients With Atrial Fibrillation

Three agents have recently been approved to reduce the risk of stroke and embolism, and one agent is in phase 3 trials. These drugs cause less serious bleeding and are simpler to manage, compared with warfarin, but they are not without their risks.
John R. Fanikos, MBA, RPh; Julie K. Atay, PharmD, MBA; and Jean M. Connors, MD

Departments

Medication Errors

‘Neither a Borrower Nor a Lender Be’ When Drugs Are Involved

Borrowing and lending drugs is a dangerous business.
Matthew Grissinger, RPh, FASCP

Prescription: Washington

DHHS Pushes to Expand E-Prescribing

Accessing Formularies in Health Plans Is a Major Problem

The DHHS pushes to expand e-prescribing. Pharmacy groups push back.
Stephen Barlas

New Drugs/Drug News/New Medical Devices

FDA approvals, drug indications, and updates

Pharmaceutical Approval Update

Bedaquiline for multiresistant pulmonary tuberculosis; Flublok influenza vaccine; and Octaplas for coagulation factor deficiency
Marvin M. Goldenberg, PhD, RPh, MS

Drug Forecast

Linaclotide (Linzess) for Irritable Bowel Syndrome With Constipation and for Chronic Idiopathic Constipation

Linaclotide (Linzess) for irritable bowel syndrome with constipation and for chronic idiopathic constipation
Rachel Hutchins Thomas, PharmD, MS; and Kyle Allmond